MORETTI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 19.384
EU - Europa 16.443
AS - Asia 3.115
AF - Africa 105
SA - Sud America 78
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 16
Totale 39.206
Nazione #
US - Stati Uniti d'America 19.150
IT - Italia 7.621
PL - Polonia 3.404
UA - Ucraina 1.934
SE - Svezia 1.136
CN - Cina 848
SG - Singapore 760
HK - Hong Kong 589
FI - Finlandia 562
TR - Turchia 469
IE - Irlanda 355
BG - Bulgaria 338
DE - Germania 247
CA - Canada 211
GB - Regno Unito 211
FR - Francia 193
NL - Olanda 119
IN - India 111
JP - Giappone 69
VN - Vietnam 68
CH - Svizzera 63
AU - Australia 57
SN - Senegal 44
IR - Iran 42
KR - Corea 42
BR - Brasile 38
BE - Belgio 37
RU - Federazione Russa 32
ES - Italia 29
CZ - Repubblica Ceca 26
RO - Romania 22
DK - Danimarca 21
EG - Egitto 19
ID - Indonesia 18
MX - Messico 18
PK - Pakistan 18
PT - Portogallo 16
AR - Argentina 14
AT - Austria 14
TN - Tunisia 13
IL - Israele 12
CL - Cile 11
EU - Europa 11
NO - Norvegia 11
TW - Taiwan 11
IQ - Iraq 9
PS - Palestinian Territory 9
SI - Slovenia 9
DZ - Algeria 8
GR - Grecia 8
NZ - Nuova Zelanda 8
SA - Arabia Saudita 8
JO - Giordania 7
MY - Malesia 7
NG - Nigeria 7
CO - Colombia 6
HR - Croazia 6
SK - Slovacchia (Repubblica Slovacca) 6
ZA - Sudafrica 6
A2 - ???statistics.table.value.countryCode.A2??? 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
HU - Ungheria 4
PE - Perù 4
PH - Filippine 4
AL - Albania 3
BY - Bielorussia 3
EC - Ecuador 3
LT - Lituania 3
LU - Lussemburgo 3
AM - Armenia 2
CR - Costa Rica 2
GT - Guatemala 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
BA - Bosnia-Erzegovina 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
KE - Kenya 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
PY - Paraguay 1
TH - Thailandia 1
VE - Venezuela 1
Totale 39.206
Città #
Warsaw 3.385
Woodbridge 2.806
Ann Arbor 2.150
Houston 2.073
Fairfield 1.729
Jacksonville 1.638
Chandler 1.141
Wilmington 1.042
Ashburn 954
Seattle 722
Princeton 635
Singapore 600
Cambridge 593
Hong Kong 565
Boardman 498
Milan 421
Izmir 365
Rome 362
Trieste 351
Dublin 340
Sofia 334
Columbus 329
Beijing 283
Toronto 166
Dearborn 126
San Diego 118
Redwood City 111
Naples 96
Verona 87
Düsseldorf 81
Chicago 76
Dong Ket 64
Bologna 63
Palermo 60
Turin 57
Santa Clara 56
Bari 51
Buffalo 51
Florence 49
Dakar 44
Genoa 44
Redmond 44
Catania 41
Hefei 39
Padova 39
Dallas 37
Falls Church 37
Venezia 37
Nanjing 36
Phoenix 36
Torino 36
Helsinki 35
Kunming 33
Norwalk 32
Brescia 31
Guangzhou 31
Washington 31
Sacile 30
Brussels 28
Mestre 27
Cagliari 26
Shanghai 24
Ankara 23
Parma 22
New York 21
Tokyo 21
Bergamo 20
Udine 20
Bremen 19
Salerno 19
Pescara 18
Pisa 18
Vicenza 18
Los Angeles 17
Brno 16
Des Moines 16
Seoul 16
Istanbul 15
Ludhiana 15
Modena 15
Jinan 14
Kocaeli 14
Pune 14
Spinea 14
Copenhagen 13
Latina 13
London 13
Pordenone 13
Zurich 13
Kamiikebukuro 12
Perugia 12
Bern 11
Curitiba 11
Fremont 11
Kolkata 11
Monza 11
Napoli 11
Rho 11
Rimini 11
Sassari 11
Totale 25.999
Nome #
Danni cerebrali post-attinici 5.693
Valutazione neuropsicologica di quattro casi di encefalopatia post-attinica. 613
Focus on Neuro Behcet's disease: a review 545
Bilirubin and inflammation in neurodegenerative and other neurological diseases 435
Wernicke Korsakoff Encephalopathy 410
Speech disorder and behavioral involvement in a thalamic stroke: a case report 377
Brain Cytochrome p450 enzymes: a possible Therapeutic Targets for Neurological Diseases 368
The controversial role of homocysteine in neurology: From labs to clinical practice 352
Basal ganglia: Their role in complex cognitive procedures in experimental models and in clinical practice 348
Subcortical vascular damages for post radiation brain radiotherapy 345
What does Doppler Ultrasonography Brings to the Diagnosis of Traumatic Vertebral Artery Dissection 330
Hepatitis C-related cryoglobulinemic neuropathy: Potential role of oxcarbazepine for pain control 326
null 319
null 312
Complex neurological symptoms in bilateral thalamic stroke due to Percheron artery occlusion 303
Cortical modulation of pupillary function: Systematic review 288
Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease 280
null 266
Management of restless legs syndrome in chronic liver disease: a challenge for the correct diagnosis and therapy 255
Earliest mechanisms of dopaminergic neurons sufferance in a novel slow progressing ex vivo model of parkinson disease in rat organotypic cultures of substantia nigra 252
Thiamine and alcohol for brain pathology: super-imposing or different causative factors for brain damage? 224
Small vessel disease to subcortical dementia: A dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit 220
Vitamin D in neurological disease: a rationale for a pathogenic impact 216
Apathy in corticobasal degeneration: possible parietal involvement 206
Non-alcoholic fatty liver disease and neurological defects 206
Thalamus and language: What do we know from vascular and degenerative pathologies 202
Olfactory loss in Multiple Sclerosis 197
Cerebral hemodynamic changes during motor imagery and passive robot-assisted movement of the lower limbs 181
Sexual dysfunction in multiple sderosis: a case-control study. 1. Frequency and comparison of groups 180
B vitamins and fatty acids: What do they share with small vessel disease-related dementia? 180
Homocysteine in neurology: From endothelium to Neurodegeneration 169
Anatomy of Basal Ganglia and Thalamus 166
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 162
Bilingual aphasia and subcortical-cortical lesions. 161
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis 160
Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms 160
null 159
Depression and Alzheimer's disease: Symptom or comorbidity? 159
Depressione vascolare e demenza vascolare sottocorticale. 155
null 152
An f-MRI evaluation of cerebrocortical activation during learned motor performance. 149
Writing errors by normal subjects. 148
Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patients 147
Ten-point clock test: a correlation analysis with other neuropsychological tests in dementia 144
Ten-Point Clock Test: a correlation analysis with mini-mental state and proverb interpretation score in Alzheimer's disease 143
Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients 142
Small vessel disease-related dementia: An invalid neurovascular coupling? 142
null 140
Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients 136
Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation. 134
Subcortical vascular dementia 133
BEHAVIORAL ALTERATIONS AND VASCULAR DEMENTIA 130
Rivastigmine and Parkinson dementia complex. 127
Corticobasal degeneration: Structural and functional MRI and single-photon emission computed tomography 127
null 127
Gabapentin for the Treatment of Behavioural Alterations in Dementia 125
An Open-Label Pilot Study Comparing Rivastigmine and Low-Dose Aspirin for the Treatment of Symptoms Specific to Patients with Subcortical Vascular Dementia 125
Memantine: reality and potentiality. 125
Gabapentin treatment of glossopharyngeal neuralgia: a follow-up of four years of a single case 124
null 123
Treatment of chronic hiccups: new perspectives 123
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 123
Cortical-basal ganglionic degeneration: a clinical, functional and cognitive evaluation (1-year follow-up) 123
null 123
A 12 MONTH FOLLOW-UP IN FIFTEEN PATIENTS WITH PARKINSON’ DISEASE: NEUROPSYCHOLOGICAL CHANGES AFTER SUBTHALAMIC NUCLEUS STIMULATION. 122
Vitamin D in the Brain Small Vessel Disease 122
null 121
Visual impairments and attention in parkinson's disease 121
null 118
Writing and praxis: what is new? 118
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up 118
Is Parkinson's disease an unique clinical entity? Rigid or tremor dominant PD: Two faces of the same coin 118
Hepatic metastasis of thymoma 117
Headache and Alzheimer's disease 117
Different responses to rivastigmine in Subcortical vascular dementia and multi- infarct dementia 116
DIFFICULTIES IN THE MANAGEMENT OF FRONTAL DEMENTIA: THERAPEUTICS STRATEGIES. 116
Dementia evaluation tests at the patient’s bedside: A neurological-internal approach. 116
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 115
null 115
Fronto-temporal dementia versus Alzheimer disease. 114
Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednysolone: a possible prophylactic treatment 114
Valutazione neuropsicologica di quattro casi di encefalopatia post-attinica. 114
Fronto-temporal dementia versus Alzheimer disease 114
NEUROPSYCHOLOGICAL EVALUATION OF LATE ONSET POST-RADIOTHERAPY ENCEPHALOPATHY: A COMPARISON WITH VASCULAR DEMENTIA. 113
Multiple sclerosis evaluation tests at the patient’s bedside: A neurological-internal approach. 113
Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy. 113
Freezing in on: significato funzionale di un sintomo o di una sindrome. 112
null 112
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases 112
Risk factors for vascular dementia: hypotension as a key point. 111
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study 111
Vitamin B12 defect: what does it mean to cognition? 111
Use of galantamine to treat vascular dementia 111
HOT TOPICS IN NEUROLOGY AND PSYCHIATRY 12 111
Gait and Apathy as Relevant Symptoms of Subcortical Vascular Dementia 111
Deep brain stimulation of the subthalamus: Neuropsychological effects 111
null 110
Bilingual aphasia and subcortical-cortical lesions. 110
Medication-overuse headache: citalopram associated with analgesics withdrawal as possible treatment 110
Apathy: A Complex Symptom Specific to the Clinical Pattern of Presentation of Parkinson’s Disease? 110
Totale 23.333
Categoria #
all - tutte 99.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.377 0 0 0 0 466 884 540 802 520 387 544 234
2020/20215.307 552 317 544 623 394 599 394 502 246 551 163 422
2021/20223.761 142 318 364 367 90 197 126 195 499 478 285 700
2022/20235.424 552 505 355 544 557 894 132 409 598 182 426 270
2023/20244.170 253 294 314 283 383 371 494 717 58 211 371 421
2024/20253.058 493 418 598 803 746 0 0 0 0 0 0 0
Totale 39.958